Eric L. Ross

1.2k total citations
21 papers, 724 citations indexed

About

Eric L. Ross is a scholar working on Infectious Diseases, Virology and Economics and Econometrics. According to data from OpenAlex, Eric L. Ross has authored 21 papers receiving a total of 724 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Virology and 6 papers in Economics and Econometrics. Recurrent topics in Eric L. Ross's work include HIV/AIDS Research and Interventions (7 papers), HIV Research and Treatment (6 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Eric L. Ross is often cited by papers focused on HIV/AIDS Research and Interventions (7 papers), HIV Research and Treatment (6 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Eric L. Ross collaborates with scholars based in United States, France and Ivory Coast. Eric L. Ross's co-authors include Kara Zivin, David W. Hutton, Daniel F. Maixner, Adam R. Glassman, Joshua D. Stein, Lee M. Jampol, Neil M. Bressler, Marc S. Weinberg, Steven E. Arnold and Rochelle P. Walensky and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Eric L. Ross

20 papers receiving 715 citations

Peers

Eric L. Ross

OPHTH

EPIDE

PHARM

Neil Roskell United States

Melissa A. Elafros United States

Mas Ayu Said Malaysia

Jyotsna Nair United States

Joseph D. Sapira United States

Maria A. Parker United States

Akira Suda Japan

Yueping Li China

Katarina Wide Sweden

Cheryl B. McCullumsmith United States

Neil Roskell United States

Eric L. Ross

140 ×0.8

24 ×0.2

OPHTH

62 ×0.4

EPIDE

58 ×0.5

91 ×0.8

PHARM

Citations per year, relative to Eric L. Ross Eric L. Ross (= 1×) peers Neil Roskell

Countries citing papers authored by Eric L. Ross

Since Specialization

Citations

This map shows the geographic impact of Eric L. Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric L. Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric L. Ross more than expected).

Fields of papers citing papers by Eric L. Ross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric L. Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric L. Ross. The network helps show where Eric L. Ross may publish in the future.

Co-authorship network of co-authors of Eric L. Ross

This figure shows the co-authorship network connecting the top 25 collaborators of Eric L. Ross. A scholar is included among the top collaborators of Eric L. Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric L. Ross. Eric L. Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zainal, Nur Hani, Robert M. Bossarte, Irving Hwang, et al.. (2024). Developing an individualized treatment rule for Veterans with major depressive disorder using electronic health records. Molecular Psychiatry. 29(8). 2335–2345. 3 indexed citations

Ross, Eric L., Robert M. Bossarte, Steven K. Dobscha, et al.. (2023). Estimated Average Treatment Effect of Psychiatric Hospitalization in Patients With Suicidal Behaviors. JAMA Psychiatry. 81(2). 135–135. 10 indexed citations

Ross, Eric L., Marc S. Weinberg, & Steven E. Arnold. (2022). Cost-effectiveness of Aducanumab and Donanemab for Early Alzheimer Disease in the US. JAMA Neurology. 79(5). 478–478. 65 indexed citations

Nock, Matthew K., Alexander J. Millner, Eric L. Ross, et al.. (2022). Prediction of Suicide Attempts Using Clinician Assessment, Patient Self-report, and Electronic Health Records. JAMA Network Open. 5(1). e2144373–e2144373. 69 indexed citations

Ross, Eric L., Marc S. Weinberg, & Steven E. Arnold. (2022). Effectiveness—Essential for Cost-effectiveness—Reply. JAMA Neurology. 79(11). 1205–1205.

Ross, Eric L., Kelly L. Zuromski, Ben Y. Reis, et al.. (2021). Accuracy Requirements for Cost-effective Suicide Risk Prediction Among Primary Care Patients in the US. JAMA Psychiatry. 78(6). 642–642. 38 indexed citations

Ross, Eric L., Jessica E. Becker, Jenny Linnoila, & Djøra I. Soeteman. (2020). Cost-Effectiveness of Routine Screening for Autoimmune Encephalitis in Patients With First-Episode Psychosis in the United States. The Journal of Clinical Psychiatry. 82(1). 6 indexed citations

Ross, Eric L. & Djøra I. Soeteman. (2020). Cost-Effectiveness of Esketamine Nasal Spray for Patients With Treatment-Resistant Depression in the United States. Psychiatric Services. 71(10). 988–997. 20 indexed citations

Ross, Eric L., Sandeep Vijan, Erin M. Miller, Marcia Valenstein, & Kara Zivin. (2019). The Cost-Effectiveness of Cognitive Behavioral Therapy Versus Second-Generation Antidepressants for Initial Treatment of Major Depressive Disorder in the United States. Annals of Internal Medicine. 171(11). 785–795. 35 indexed citations

10.

Freedberg, Kenneth A., Nagalingeswaran Kumarasamy, Ethan D. Borre, et al.. (2018). Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India. AIDS Research and Human Retroviruses. 34(6). 486–497. 2 indexed citations

11.

Ross, Eric L., Kara Zivin, & Daniel F. Maixner. (2018). Cost-effectiveness of Electroconvulsive Therapy vs Pharmacotherapy/Psychotherapy for Treatment-Resistant Depression in the United States. JAMA Psychiatry. 75(7). 713–713. 98 indexed citations

12.

Ross, Eric L., David W. Hutton, Joshua D. Stein, et al.. (2016). Cost-effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Treatment. JAMA Ophthalmology. 134(8). 888–888. 148 indexed citations

13.

Ross, Eric L., Sandro Cinti, & David W. Hutton. (2016). Implementation and Operational Research: A Cost-Effective, Clinically Actionable Strategy for Targeting HIV Preexposure Prophylaxis to High-Risk Men Who Have Sex With Men. JAIDS Journal of Acquired Immune Deficiency Syndromes. 72(3). e61–e67. 25 indexed citations

14.

Ross, Eric L., Milton C. Weinstein, Bruce R. Schackman, et al.. (2015). The Clinical Role and Cost-Effectiveness of Long-Acting Antiretroviral Therapy. Clinical Infectious Diseases. 60(7). 1102–1110. 38 indexed citations

15.

Ouattara, Éric, Eric L. Ross, Yazdan Yazdanpanah, et al.. (2014). Clinical Impact and Cost-Effectiveness of Making Third-Line Antiretroviral Therapy Available in Sub-Saharan Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 66(3). 294–302. 5 indexed citations

16.

Ross, Eric L., Frank Tanser, Marie‐Louise Newell, et al.. (2014). The Impact of the 2013 WHO Antiretroviral Therapy Guidelines on the Feasibility of HIV Population Prevention Trials. HIV Clinical Trials. 15(5). 185–198. 5 indexed citations

17.

Ross, Eric L.. (2013). MODELING HIV TRANSMISSION DYNAMICS IN CONJUNCTION WITH A MICROSIMULATION OF DISEASE PROGRESSION. 1 indexed citations

18.

Walensky, Rochelle P., Eric L. Ross, Nagalingeswaran Kumarasamy, et al.. (2013). Cost-Effectiveness of HIV Treatment as Prevention in Serodiscordant Couples. New England Journal of Medicine. 369(18). 1715–1725. 104 indexed citations

19.

Yazdanpanah, Yazdan, Julian Perelman, Joana Alves, et al.. (2013). Routine HIV Screening in Portugal: Clinical Impact and Cost-Effectiveness. PLoS ONE. 8(12). e84173–e84173. 46 indexed citations

20.

Ross, Eric L., et al.. (1978). A comparison of treatment effectiveness of nonaddict and exaddict professionals in an adolescent treatment program. Drug and Alcohol Dependence. 3(5). 319–329. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact